Firefly Neuroscience, Inc. (AIFF)
NCM · Technology · Software - Application
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 299K | 388K | 412K | 485K |
| Gross Profit | 274K | 146K | 182K | 221K |
| Operating Income | -1.6M | -2.5M | -2.4M | -2.0M |
| Net Income | -1.8M | -2.6M | -2.5M | -2.0M |
| Diluted EPS | $-0.14 | $-0.20 | $nan | $-0.13 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 498K | 108K | 1.1M |
| Gross Profit | 0.00 | 498K | 108K | 645K |
| Operating Income | -3.3M | -3.1M | -9.2M | -8.6M |
| Net Income | -3.8M | -2.6M | -10.5M | -19.9M |
| Diluted EPS | $-0.73 | $-0.50 | $-1.60 | $-1.97 |